(all times are US Eastern)
Friday May 9, 2008

• Semi-Annual Changes to the NASDAQ Biotechnology Index
  8:00 pm - PrimeNewswire
• Therapeutic DNA Vaccine Company Inovio Biomedical Reports First Quarter 2008 Financial Results
  6:24 pm - Business Wire
• UPDATE - Actress Uma Thurman sues Lancome in NY for $15 mln
  5:55 pm - at Reuters
• EpiCept Announces Receipt of Nasdaq Determination
  5:55 pm - Business Wire
• Keryx Biopharmaceuticals, Inc. Announces First Quarter 2008 Financial Results
  5:30 pm - PR Newswire
• Victhom discloses first quarter 2008 financial results
  5:24 pm - CNW Group
• Repros Therapeutics Inc. Reports First Quarter 2008 Financial Results and Provides Clinical Development Program Overview
  5:23 pm - Business Wire
• Elixir Pharmaceuticals withdraws IPO plans
  5:14 pm - at Reuters
• WorldHeart Reports an Event of Default Under the Note Issued to Abiomed, Resignation of One of Its Board of Directors, and Results of Shareholder Vote at Its Annual Shareholders' Meeting
  5:03 pm - PR Newswire
• SomaLogic and Otsuka Enter Into Research Collaboration
  5:03 pm - PR Newswire
• Aldagen Inc files for $80.5 million IPO
  5:02 pm - at Reuters
• BioSante Pharmaceuticals Reports First Quarter 2008 Financial Results
  5:00 pm - Business Wire
• Oakmark Global Fund reopens to all new investors
  4:39 pm - at Reuters
• Bionovo Reports First Quarter 2008 Financial Results
  4:30 pm - PR Newswire
• US STOCKS-AIG's loss and record oil sour mood on Wall St
  4:27 pm - at Reuters
• Genaera Corporation Announces First Quarter Financial Results
  4:20 pm - PR Newswire
• UPDATE - Barr gets US FDA OK for generic Yasmin contraceptive
  4:17 pm - at Reuters
• Cardium Reports on First Quarter 2008 Highlights and Financial Results
  4:15 pm - PR Newswire
• Gilead Sciences to Present at the Bank of America 2008 Healthcare Conference on Tuesday, May 13
  4:15 pm - Business Wire
• Omnicare to Present at the Bank of America Healthcare Conference
  4:00 pm - Business Wire
• Barr Announces Approval of Generic Yasmin(R)
  3:35 pm - PR Newswire
• Notice of Time Change for Alexion's Presentation at the Bank of America 2008 Health Care Conference
  3:33 pm - PR Newswire
• Moffitt Cancer Center Joins National Campaign To Implore Americans To Donate $1 To Accelerate Cancer Research
  3:22 pm - PR Newswire
• UPDATE - Zimmer chief marketing officer to leave company
  2:50 pm - at Reuters
• VirtualScopics Announces Results of Annual Stockholders' Meeting
  2:32 pm - PrimeNewswire
• Kiwa Bio-Tech 1st Quarter Revenues Increase 57.8% - $2.18 Million
  2:30 pm - PR Newswire
• UPDATE - US high-grade company debt sales rise to $33 bln
  2:29 pm - at Reuters
• CORRECTING and REPLACING St. Jude Medical Announces Results of Shareholders' Vote at Annual Meeting
  2:20 pm - Business Wire
• UPDATE - US clears new version of Novo Nordisk clot therapy
  1:59 pm - at Reuters
• Farm Bill Provisions Can Spur Production of Advanced, Low-Carbon Biofuels
  1:40 pm - Business Wire
• Schering-Plough Schedules Webcast for Annual Meeting of Shareholders
  1:37 pm - PR Newswire
• US clears new version of Novo Nordisk clot therapy
  1:29 pm - at Reuters
• NeuroFocus Chief Science Advisor Wins Humboldt Prize
  12:25 pm - PR Newswire
• AACE Calls for New Standards for Safer Insulin Pump Use
  12:13 pm - Business Wire
• Results of Court Meeting and Extraordinary General Meeting - Shareholders Approve Scheme of Arrangement and New Share Plans
  12:08 pm - PR Newswire
• BioMS Medical Provides Update On Pipeline Products
  12:00 pm - PR Newswire
• ATS Medical to Participate at the Rodman & Renshaw 5th Annual Global Healthcare Conference
  11:58 am - PR Newswire
• Genetic Immunity To Present at the Rodman & Renshaw 5th Annual Global Healthcare Conference
  11:25 am - PR Newswire
• UPDATE - Sanofi, BMS hit by generic Plavix threat in Europe
  11:23 am - at Reuters
• BioMimetic Therapeutics, Inc. to Highlight Corporate Activities at Bank of America Securities 2008 Healthcare Conference
  11:19 am - Business Wire
• Oncolytics Biotech Inc. Starts Patient Enrolment in U.K. Combination REOLYSIN(R)/Cyclophosphamide Trial
  10:55 am - PR Newswire
• Alpharma Files Form 10-Q for the Three Months Ended March 31, 2008
  10:46 am - Marketwire
• Millstone Medical Outsourcing Achieves Quality Advantages in Memphis: Certified ISO 13485, Hires Experienced Quality Manager
  10:43 am - PR Newswire
• Green Yeast (ATCI.OB) Trades Again
  10:18 am - Marketwire
• Oragenics Announces Test Marketing of Probiora3(TM) Chewable Tablets
  10:11 am - Marketwire
• CORRECTING and REPLACING Progenics Pharmaceuticals Reports First Quarter 2008 Results
  10:09 am - Business Wire
• RPT-UPDATE - Mylan posts bigger loss after charges; shares fall
  10:06 am - at Reuters
• Celator(R) Pharmaceuticals Announces Appointment of Scott Jackson as CEO
  10:00 am - PR Newswire
• Ambrilia: Conference Call and Webcast for First Quarter 2008 Results
  10:00 am - Marketwire
• Synta Pharmaceuticals to Host First-Quarter 2008 Conference Call on May 14, 2008
  10:00 am - Business Wire
• PolyMedix Receives Regulatory Clearance to Initiate Phase I Clinical Study of Novel Systemic Antibiotic Compound
  9:56 am - Business Wire
• Javelin Pharmaceuticals to Announce First Quarter 2008 Financial Results
  9:55 am - Business Wire
• UPDATE - UBS starts Abbott Laboratories with buy
  9:42 am - at Reuters
• XenoPort to Present at Upcoming Conferences
  9:30 am - Business Wire
• UPDATE - Warner Chilcott swings to Q1 profit, ups '08 share view
  9:22 am - at Reuters
• Enzo Biochem Acquires BIOMOL International, Further Expanding Its Life Sciences Operations
  9:10 am - Business Wire
• Pulmo BioTech Announces an Increase in its Stake in PulmoScience
  9:00 am - PR Newswire
• International Center for Adult Stem Cell Education Debuts at Spinal Cord Injury Symposium in Greece
  9:00 am - PR Newswire
• There are no Less than 280 Therapeutics Targeting Prostate Cancer Today
  9:00 am - Business Wire
• GPC Biotech Schedules Conference Call on May 15th to Discuss First Quarter 2008 Financial Results
  9:00 am - Business Wire